ArticleCanadian journal of gastroenterology & hepatology2021

A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.

Torsten Diesinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.